House Panel Criticizes F.D.A. Role in Drug Cases
Wednesday, April 30, 2008 - 13:46
in Health & Medicine
The Food and Drug Administration was criticized for not doing more checks of foreign drug manufacturers in the wake of problems with the blood thinner heparin and other products.
Read the whole article on NY Times Health
More from NY Times Health
Related
- Patient safety advanced by revised heparin standardsThu, 30 Jul 2009, 11:25:57 EDT
- Simple new method detects contaminants in life-saving drugMon, 17 Nov 2008, 16:57:19 EST
- Cell-coated stent as effective as drug-coated ones but needs less medsTue, 11 Nov 2008, 12:09:24 EST
- Designing drugs and their antidotes together improves patient careSun, 4 Oct 2009, 13:44:16 EDT
- ICT fails to accelerate drug approvalsThu, 19 Nov 2009, 9:58:09 EST